Abstract
Introduction
Fertility preservation needs have increased dramatically in recent years due to a rising cancer incidence and also a significant increase in survival rates.
Materials and methods
We report on 200 women participating in the Valencia Programme for Fertility Preservation, of whom 55% were breast cancer patients, 25% Hodgkin’s disease patients, and the remaining 20% suffered from other nonmalignant and malignant diseases. Mean age was 28.2 years (11–39). Before patients were submitted to oncological treatment, the right ovarian cortex was extracted by laparoscopy and cryopreserved. Once the patient was free of disease, the right ovarian cortex was thawed and implanted onto the left ovarian medulla (after extraction at the same surgical time of left ovarian cortex).
Results
In 95% of cases, a piece ∼2 × 3 cm was obtained. The procedure did not cause any change in the cancer therapy schedule. Four implants had been performed (all of them in women who underwent chemotherapy prior to ovarian cortex extraction), from which two of the cases achieved ovarian function resumption, in one case a month after the implant and in the other 5.5 months after. The remaining two implanted cases were performed 5 and 6 months prior to the writing of this paper, respectively.
Conclusions
Ovarian tissue cryopreservation is a feasible option to preserve ovarian function and possibly fertility in adolescents and young women at risk of developing premature ovarian failure (POF) due to chemotherapy and/or radiotherapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jemal A, Clegg LX, Ward E et al (2004) Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 101:3–27
Pizzo PA, Poplack DG (eds) (2006) Principles and practice of pediatric oncology. 5th edn. Lippincott Williams and Wilkins, Philadelphia
Viviani S, Santoro A, Ragni G et al (1985) Gonadal toxicity after combination chemotherapy for Hodgkin’s disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 21:601–605
Ghafoor A, Jemal A, Ward E et al (2003) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53:342–355
Apperley JF, Reddy N (1995) Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood Rev 9:93–116
Meirow D, Nugent D (2001) The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 7:535–543
Lee SJ, Schover LR, Partridge AH Patrizio P et al (2006) American Society of Clinical Oncology Recommendations on Fertility Preservation in People Treated for Cancer. J Clin Oncol 24:2917–2931.
Donnez J, Dolmans MM, Demylle D et al (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364:1405–1410
Demeestere I, Simon P, Emiliani S et al (2007) Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin’s disease. Oncologist 12:1437–1442
Meirow D, Levron J, Eldar-Geva T et al (2005) Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 353:318–321
Liu L, Wood GA, Morikawa L (2008) Restoration of fertility by orthotopic transplantation of frozen adult mouse ovaries. Hum Reprod 23:122–128.
Kim SS, Yang HW, Kang HG et al (2004) Quantitative assessment of ischemic tissue damage in ovarian cortical tissue with or without antioxidant (ascorbic acid) treatment. Fertil Steril 82:679–685
Liu J, Van der Elst J, Van der Broecke R, Dhont M (2002) Early massive follicle loss and apoptosis in heterotopically grafted newborn mouse ovaries. Hum Reprod 17:605–611
Sánchez M, Alama P, Gadea B et al (2007) Fresh human orthotopic ovarian cortex transplantation: long-term results. Hum Reprod 22:786–791
Oktay K, Karlikaya (2000). Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 342:1919
Radford JA, Lieberman BA, Brison D et al (2001) Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin’s lymphoma. Lancet 357:1172–1175
Schmidt KL, Andersen CY, Loft A et al (2005) Follow-up of ovarian function post-chemotherapy following ovarian cryopreservation and transplantation. Hum Reprod 20:3539–3546
Donnez J, Dolmans MM, Demylle D et al (2006) Restoration of ovarian function after orthotopic (intraovarian and periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anemia: case report. Hum Reprod 21:183–188
Demeestere I, Simon P, Buxant F et al (2006) Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod 21:2010–2014.
Thewes B, Meiser B, Taylor A et al (2005) Fertility-and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 23:5155–5165
Oktay K, Hourwitz A, Sahin G et al (2006) Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91:3885–3890
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sánchez, M., Novella-Maestre, E., Teruel, J. et al. The valencia programme for fertility preservation. Clin Transl Oncol 10, 433–438 (2008). https://doi.org/10.1007/s12094-008-0227-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-008-0227-4